<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859907</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1472</article-id><article-id pub-id-type="other">EPV0858</article-id><article-id pub-id-type="pii">S092493382401472X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Virtual Reality as Exposure Therapy in the Treatment of Blood-Injection-Injury Phobias</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Halouani</surname><given-names>N.</given-names></name><xref rid="aff3236" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Boussaid</surname><given-names>N.</given-names></name><xref rid="aff3236" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Turki</surname><given-names>M.</given-names></name><xref rid="aff3236" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Barkallah</surname><given-names>M.</given-names></name><xref rid="aff3236" ref-type="aff"/><xref rid="cor1321" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ellouze</surname><given-names>S.</given-names></name><xref rid="aff3236" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Aloulou</surname><given-names>J.</given-names></name><xref rid="aff3236" ref-type="aff"/></contrib></contrib-group><aff id="aff3236">psychiatrie B, <institution>Hedi Chaker university hospital</institution>, <city>Sfax</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor1321"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1447">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S707</fpage><lpage>S707</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382401472Xa.pdf"/><abstract><sec id="sec7941"><title>Introduction</title><p>
Virtual Reality (VR) is a transformative technology that facilitates the development of immersive virtual environments. Its application is steadily growing within Cognitive Behavioral Therapy (CBT) techniques, notably in virtuo exposure therapy. This is particularly evident in the treatment of specific phobias, with a specific focus on addressing blood-injection-injury phobias.</p></sec><sec id="sec7942"><title>Objectives</title><p>The objective of our study is to design a treatment protocol for patients suffering from blood phobia based on VR.</p></sec><sec id="sec7943"><title>Methods</title><p>We used the following scales:
<list list-type="bullet"><list-item><p>Fear Survey Schedule-III (FSS-III) and the Injection Phobia Scale (IPS) for psychometric evaluation of the intensity of avoidance fear.</p></list-item><list-item><p>Questionnaire on cybersickness: to identify potential adverse effects of exposure to virtual reality.</p></list-item></list></p><p>To conduct a functional analysis of phobias, we used the SECCA grid and the SORC grid.</p></sec><sec id="sec7944"><title>Results</title><p>The therapeutic protocol stages of VR for a patient suffering from Blood-Injection-Injury Phobia (BIIP) are as follows:<list list-type="order"><list-item><p>Collection of sociodemographic and clinical data.</p></list-item><list-item><p>Functional analysis to identify triggering factors, contributing factors, and consequences of behavior. The SECCA or SORC grid can help in conducting this functional analysis.</p></list-item><list-item><p>Psychometric evaluation of the intensity of avoidance fear using the three scales: FSS-III, IPS, and the cybersickness scale.</p></list-item><list-item><p>Patient education on the mechanisms of the phobia.</p></list-item><list-item><p>Setting of objectives.</p></list-item><list-item><p>Therapeutic contract.</p></list-item><list-item><p>The Protocol :</p></list-item><list-item><p>Cognitive approach: identification of automatic thoughts and replacement with more rational thoughts.</p></list-item><list-item><p>Behavioral approach: Progressive exposure, controlled immersion of the patient in virtual environments corresponding to situations that trigger their phobia. This exposure is coupled with relaxation.</p></list-item></list></p><p>The treatment continues with regular follow-up to ensure the consolidation of progress and to adjust strategies.</p><p>For relapse prevention, simple measures ,like personalized exercises to be done by the patient, can favor the long-term maintenance of the acquired skills.</p></sec><sec id="sec7945"><title>Conclusions</title><p>
Virtual reality exposure therapies (in virtuo) are as effective as in-vivo therapies. Besides, they offer a significant advantage over the latter as they facilitate access to stimuli or anxiety-provoking situations that are difficult to access or control in the real world.</p></sec><sec id="sec7946"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>